Table 3.
Factors for Alzheimer dementia among different usages of antibiotics by using Fine and Gray's competing risk model.
Medications | Adjusted HR | 95% CI | 95% CI | P | |
---|---|---|---|---|---|
Macrolides | Without Chlamydia pneumoniae | Reference | |||
With Chlamydia pneumoniae | |||||
Without Macrolides | 2.177 | 1.865 | 2.468 | <0.001 | |
with Macrolides 1–7 days | 1.483 | 1.069 | 1.825 | 0.003 | |
with Macrolides 8–14 days | 1.592 | 1.276 | 1.899 | <0.001 | |
with Macrolides≥15 days | 1.198 | 0.929 | 1.487 | 0.304 | |
Fluoroquinolones | Without Chlamydia pneumoniae | Reference | |||
With Chlamydia pneumoniae | |||||
Without Fluoroquinolones | 1.996 | 1.395 | 2.896 | <0.001 | |
With Fluoroquinolones 1-7 days | 1.506 | 1.283 | 1.883 | <0.001 | |
With Fluoroquinolones 8-14 days | 1.385 | 1.106 | 1.796 | 0.001 | |
With Fluoroquinolones≥15 days | 1.302 | 0.973 | 1.656 | 0.391 |
PYs, Person-years; Adjusted HR, Adjusted variables listed in the table; CI, confidence interval; P, Chi-square/Fisher exact test on category variables and t-test on continue variable.